LEO Pharma Reinforces Leadership in Medical Dermatology with New Data from Across Its Portfolio at 2025 Fall Clinical Dermatology Conference

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on ...
Wigan Today on MSN

Health Column: Stop the spread - simple steps to prevent winter infections

Julie O’Malley, Deputy Director of Infection, Prevention and Control Wrightington, Wigan and Leigh Teaching Hospitals NHS ...
PharmiWeb

Subcutaneous RYBREVANT® (amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...
The Atlanta Journal-Constitution

Don’t drop the flu shot from your to-do list

Don’t let a busy schedule keep you from getting your flu shot for the 2025–2026 season. It’s a simple step that can offer strong protection against serious illness.